Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahan B W Liyanagedera

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cellular and Infection Microbiology|November 7, 2025
Synthetic cells for phage therapy: a perspectiveVishwesh Kulkarni, Nadanai Laohakunakorn, Sahan B W Liyanagedera
ACS Synthetic Biology|January 4, 2025
ATP Regeneration from Pyruvate in the PURE SystemSurendra Yadav, Alexander J P Perkins, Sahan B W Liyanagedera, et al.
Journal of Visualized Experiments : Jove|September 8, 2025
Refinement of OnePot PURE and Crude Ribosome Production for Reproducible Cell-free Protein SynthesisSahan B W Liyanagedera, Anthony Bougas, Surendra Yadav, et al.
ACS Synthetic Biology|October 4, 2022
SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage TherapiesSahan B W Liyanagedera, Joshua Williams, Joseph P Wheatley, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular and Infection Microbiology|November 7, 2025
Synthetic cells for phage therapy: a perspectiveVishwesh Kulkarni, Nadanai Laohakunakorn, Sahan B W Liyanagedera
ACS Synthetic Biology|January 4, 2025
ATP Regeneration from Pyruvate in the PURE SystemSurendra Yadav, Alexander J P Perkins, Sahan B W Liyanagedera, et al.
Journal of Visualized Experiments : Jove|September 8, 2025
Refinement of OnePot PURE and Crude Ribosome Production for Reproducible Cell-free Protein SynthesisSahan B W Liyanagedera, Anthony Bougas, Surendra Yadav, et al.
ACS Synthetic Biology|October 4, 2022
SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage TherapiesSahan B W Liyanagedera, Joshua Williams, Joseph P Wheatley, et al.
Pageof 1